LENZ Therapeutics News

LENZ Therapeutics | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans

May 21 08:35 ET

LENZ Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Chevallard Daniel R.

May 15 16:22 ET

LENZ Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director MCCOLLUM JAMES W

May 14 17:35 ET

LENZ Therapeutics | 424B3: Prospectus

May 9 16:24 ET

LENZ Therapeutics | 10-Q: Quarterly report

May 8 17:17 ET

LENZ Therapeutics | 8-K: LENZ Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Updates

May 8 16:10 ET

LENZ Therapeutics | 424B3: Prospectus

Apr 11 14:36 ET

LENZ Therapeutics | EFFECT: Others

Apr 11 06:05 ET

LENZ Therapeutics | S-1/A: General form for registration of securities under the Securities Act of 1933 (Amendment)

Apr 9 14:30 ET

LENZ Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-EcoR1 Capital, LLC(4.8%),Oleg Nodelman(4.8%), etc.

Apr 8 14:48 ET

LENZ Therapeutics | CORRESP: CORRESP

Apr 8 14:44 ET

LENZ Therapeutics | UPLOAD: Others

Apr 3 14:44 ET

LENZ Therapeutics | 8-K: Current report

Apr 3 07:37 ET

LENZ Therapeutics | S-1: General form for registration of securities under the Securities Act of 1933

Mar 29 16:48 ET

LENZ Therapeutics | SC 13D: Statement of acquisition of beneficial ownership by individuals-RA Capital Management, L.P.(16.6%),Peter Kolchinsky(16.6%), etc.

Mar 28 22:40 ET

LENZ Therapeutics | 3: Initial statement of beneficial ownership of securities-10% Owner Alpha Wave Ventures GP, Ltd

Mar 28 22:16 ET

LENZ Therapeutics | SC 13G: Statement of acquisition of beneficial ownership by individuals-Alpha Wave Global, LP(14.1%),Alpha Wave Ventures GP, Ltd(14.1%), etc.

Mar 28 16:36 ET

Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director RA CAPITAL MANAGEMENT, L.P.

Mar 25 20:50 ET

Therapeutics | 3: Initial statement of beneficial ownership of securities-Director RA CAPITAL MANAGEMENT, L.P.

Mar 25 20:45 ET

Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Thunen Shelley B

Mar 25 20:45 ET